EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

After total hip arthroplasty, patients with glucocorticoid-treated osteonecrosis of the femoral head have a higher risk of in-hospital reoperation: a nationwide propensity score-matched analysis

Hidetatsu Tanaka, Kunio Tarasawa, Yu Mori, Kazuyoshi Baba, Hideki Fukuchi, Hiroki Kawamata, Kiyohide Fushimi, Toshimi Aizawa, Kenji Fujimori

International Orthopaedics · 2026

DOI: 10.1007/s00264-026-06875-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Orthopaedics, 2026. Verfasst von Hidetatsu Tanaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan. hidetatsu.tanaka.c7@tohoku.ac.jp. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Reoperation, Femur Head Necrosis, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Inpatient glucocorticoid treatment has been associated with increased postoperative complications after total hip arthroplasty (THA). However, evidence specific to osteonecrosis of the femoral head (ONFH) remains limited and inconsistent. This study aimed to evaluate the association between inpatient glucocorticoid treatment and early postoperative complications after THA for ONFH using a nationwide database.

Methods

This retrospective cohort study used the Japanese Diagnosis Procedure Combination database from 2011 to 2023. Patients undergoing THA for ONFH were identified and categorized according to inpatient glucocorticoid treatment. Propensity score matching was performed using demographic and perioperative variables. The primary outcome was reoperation during hospitalization. Secondary outcomes included surgical and medical complications and in-hospital mortality. Multivariate logistic regression analysis was performed to identify independent risk factors.

Results

After propensity score matching, 19,154 patients were included. Inpatient glucocorticoid treatment was independently associated with an increased risk of reoperation (odds ratio [OR], 1.73; 95% confidence interval [CI], 1.26–2.37; p < 0.001). No significant associations were observed between inpatient glucocorticoid treatment and dislocation (OR, 1.17; p = 0.45), surgical site infection (OR, 1.03; p = 0.86), periprosthetic fracture (OR, 1.38; p = 0.24), or in-hospital mortality (OR, 1.69; p = 0.35). Medical complications were also not significantly different between the groups. Closed reduction and revision arthroplasty were the most common reoperations in both groups.

Conclusion

Patients receiving inpatient glucocorticoid treatment had a higher risk of reoperation after THA for ONFH, despite no significant increase in most early postoperative complications. These findings suggest that patients receiving inpatient glucocorticoid treatment may represent a medically vulnerable population at increased risk of early postoperative reoperation after THA. Careful perioperative management may be warranted in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipReoperationFemur Head NecrosisGlucocorticoidsPostoperative ComplicationsHumansFemaleMaleMiddle AgedRetrospective StudiesPropensity ScoreRisk FactorsAgedAdultJapanHospital Mortality

Stichwörter der Autor:innen

GlucocorticoidLarge data baseOsteonecrosis of the femoral headPost-operative complicationsTotal hip arthroplasty

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan. hidetatsu.tanaka.c7@tohoku.ac.jp.
  • Department of Medical Information Technology Center, Tohoku University Hospital, Sendai, Japan.
  • Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Health Policy and Informatics, Institute of Science Tokyo, Tokyo, Japan.
  • Tohoku University, Sendai, Japan.

Zitieren

APA

Tanaka, H., Tarasawa, K., Mori, Y., Baba, K., Fukuchi, H., Kawamata, H., Fushimi, K., Aizawa, T., & Fujimori, K. (2026). After total hip arthroplasty, patients with glucocorticoid-treated osteonecrosis of the femoral head have a higher risk of in-hospital reoperation: a nationwide propensity score-matched analysis. International Orthopaedics. https://doi.org/10.1007/s00264-026-06875-3

Vancouver

Tanaka H, Tarasawa K, Mori Y, Baba K, Fukuchi H, Kawamata H, et al. After total hip arthroplasty, patients with glucocorticoid-treated osteonecrosis of the femoral head have a higher risk of in-hospital reoperation: a nationwide propensity score-matched analysis. International Orthopaedics. 2026. doi:10.1007/s00264-026-06875-3

BibTeX
@article{Tanaka2026,
  author = {Tanaka, Hidetatsu and Tarasawa, Kunio and Mori, Yu and Baba, Kazuyoshi and Fukuchi, Hideki and Kawamata, Hiroki and Fushimi, Kiyohide and Aizawa, Toshimi and Fujimori, Kenji},
  title = {After total hip arthroplasty, patients with glucocorticoid-treated osteonecrosis of the femoral head have a higher risk of in-hospital reoperation: a nationwide propensity score-matched analysis},
  journal = {International Orthopaedics},
  year = {2026},
  doi = {10.1007/s00264-026-06875-3}
}
Kostenlos starten →